Positive CHMP opinion is based on data from the DEVOTE study which evaluated the high dose regimen of nusinersen in treatment-naive participants and those transitioning from the currently approved 12m ...

STOCKHOLM - November 17, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company ...

PANO - On 5, Flotilla 11 under the Coast Guard Region 1 Command, in coordination with the Hung Yen provincial Party Committee ...